4SC AG (FRA:VSC) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is 4SC AG Days Payable?

4SC AG's average Accounts Payable for the six months ended in Dec. 2023 was €0.46 Mil. 4SC AG's Cost of Goods Sold for the six months ended in Dec. 2023 was €-0.01 Mil.

The historical rank and industry rank for 4SC AG's Days Payable or its related term are showing as below:

FRA:VSC' s Days Payable Range Over the Past 10 Years
Min: 74.61 Med: 1240.96 Max: 3654.8
Current: 2177.19

During the past 13 years, 4SC AG's highest Days Payable was 3654.80. The lowest was 74.61. And the median was 1240.96.

FRA:VSC's Days Payable is ranked better than
89.44% of 720 companies
in the Biotechnology industry
Industry Median: 147.17 vs FRA:VSC: 2177.19

4SC AG's Days Payable declined from Dec. 2022 (3,978.50) to Dec. 2023 (0.00). It may suggest that 4SC AG accelerated paying its suppliers.

4SC AG Days Payable Historical Data

The historical data trend for 4SC AG's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4SC AG Days Payable Chart

4SC AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

1,382.77

840.06

1,260.82

2,990.65

2,251.47

4SC AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															1,374.67	1,657.10	3,978.50	1,178.20	-

Competitive Comparison of 4SC AG's Days Payable

For the Biotechnology subindustry, 4SC AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4SC AG's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4SC AG's Days Payable distribution charts can be found below:

* The bar in red indicates where 4SC AG's Days Payable falls into.

4SC AG Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

4SC AG's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.789	+	0.383)	/	2 )	/	0.095	*	365
=	0.586					/	0.095	*	365
=	2,251.47

4SC AG's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.528	+	0.383)	/	2 )	/	-0.007	*	365 / 2
=	0.4555					/	-0.007	*	365 / 2
=	N/A

4SC AG Days Payable Related Terms

Thank you for viewing the detailed overview of 4SC AG's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

4SC AG (FRA:VSC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4SC AG (FRA:VSC) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

VSC:Germany

Address

Fraunhoferstraße 22, Planegg-Martinsried, DEU, 82152

Website

https://www.4sc.com

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. It Geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.

4SC AG (FRA:VSC) Headlines

No Headlines